Key result
Whole nerve electrophysiology tracks diabetic symmetrical polyneuropathy progression but only assesses large myelinated axons.
Why the study?
Whole nerve electrophysiology provides objective measures sensitive to diabetic symmetrical polyneuropathy progression but indexes limited neural activity aspects and large myelinated axons only.
Does whole nerve electrophysiology accurately assess the progression of diabetic symmetrical polyneuropathy?
Does whole nerve electrophysiology accurately assess the progression of diabetic symmetrical polyneuropathy?
Whole nerve electrophysiology is a useful but limited tool for assessing diabetic neuropathy, primarily reflecting large myelinated axon function.
Answers are grounded in this paper and cite their sources.
Limits assessment of diabetic neuropathy progression to large myelinated fibers; leaves open need for small-fiber measures in future studies.
Whole nerve electrophysiology can provide a battery of objective, reliable and specific measures that are sensitive to the progression of diabetic symmetrical polyneuropathy (DSPN). However, under standard conditions, these measures index limited aspects of neural activity, and then only in large diameter, myelinated axons. Nerve conduction is not synonymous with "nerve function." Electrophysiologic measures can be influenced by a variety of factors with different time courses of action and with different sensitivities to manipulation. The value of whole nerve electrophysiology must be based on a firm appreciation of the strengths and limitations of the procedure.
No takes yet. Share an insight, caveat, or question.
Joseph C. Arezzo (1997) conducted a review in Diabetic symmetrical polyneuropathy (DSPN). Whole nerve electrophysiology was evaluated. Whole nerve electrophysiology provides objective measures sensitive to diabetic symmetrical polyneuropathy progression, but is limited to indexing activity in large diameter, myelinated axons.
Synapse has enriched 10 related papers. Consider them for comparative context: